Polyacrylamide Gel
1094
0043240 0043241 0043242 0043243 0043244 0043245 0043246 0043426 1853210
1853220 1856138 1886620 1886620B 1886940
5/22/2008.
5/22/2008.
Material Safety Data Sheet
Product name
Manufacturer
Product No.
MSDS #
Validation date
Print date
In case of emergency
Product and company identification
Responsible name
MSDS (Regulatory Affairs)
Polyacrylamide Gel
:
:
:
:
:
:
:
1 .
CHEMTREC:
800.424.9300
OUTSIDE US:
202.483.7616
Supplier
: Thermo Fisher Scientific
Pierce Biotechnology
P.O. Box 117
Rockford, IL 61105
United States
815.968.0747 or
800.874.3723
:
Use of
Substance/Preparation
Refer to the instruction booklet for
proper and intended use.
Otherwise, contact supplier for
specific applications.
: Thermo Fisher Scientific
Pierce Biotechnology
P.O. Box 117
Rockford, IL 61105
United States
815.968.0747
800.874.3723
Dermal contact. Eye contact. Inhalation. Ingestion.
Emergency overview
Hazards identification
Routes of entry
Potential acute health effects
Exposure to decomposition products may cause a health hazard. Serious effects may
be delayed following exposure.
No known significant effects or critical hazards.
No known significant effects or critical hazards.
No known significant effects or critical hazards.
Eyes
Skin
Inhalation
Ingestion
Physical state
Liquid. [Gelatinous precipitate.]
NOT EXPECTED TO PRODUCE SIGNIFICANT ADVERSE HEALTH EFFECTS WHEN
THE RECOMMENDED INSTRUCTIONS FOR USE ARE FOLLOWED.
No known significant effects or critical hazards. Avoid prolonged contact with eyes, skin
and clothing.
:
:
:
:
:
:
:
OSHA/HCS status
: While this material is not considered hazardous by the OSHA Hazard Communication
Standard (29 CFR 1910.1200), this MSDS contains valuable information critical to the
safe handling and proper use of the product. This MSDS should be retained and
available for employees and other users of this product.
2 .
Potential chronic health effects
Carcinogenicity
: No known significant effects or critical hazards.
Mutagenicity
: No known significant effects or critical hazards